What medications are used to reduce inflammation in sarcoidosis? 

Sarcoidosis is an inflammatory condition that causes the immune system to create small, inflamed clusters of tissue called granulomas within the body’s organs. While many people do not require immediate medical intervention as the condition often resolves naturally, medication becomes necessary when the inflammation threatens organ function or causes severe symptoms. The primary goal of pharmaceutical treatment is to dampen the immune system’s overactive response, thereby reducing the size and number of these granulomas and preventing permanent tissue damage. 

What We’ll Discuss in This Article 

• The role of corticosteroids as the primary treatment for inflammation. 

• Second-line immunosuppressant medications used to spare the use of steroids. 

• Advanced biological therapies for severe or resistant cases. 

• Topical treatments for localised skin and eye involvement. 

• How medication choices are tailored to specific organ involvement. 

• The importance of clinical monitoring during a course of treatment. 

Corticosteroids as the first line of treatment 

Corticosteroids are the most common medications used to rapidly reduce inflammation in sarcoidosis by suppressing the body’s overactive immune response. In the United Kingdom, the standard corticosteroid prescribed is prednisolone, which is usually taken in tablet form. These medications work by “switching off” the inflammatory signals that lead to the formation of granulomas, helping to relieve symptoms like breathlessness and persistent coughing. 

According to NHS guidance, steroids are typically started at a higher dose to bring the inflammation under control before being gradually reduced over several months. While highly effective, they are associated with side effects such as weight gain, mood changes, and increased blood sugar, so they are only used when the benefits to organ function outweigh these risks. Most patients find that a carefully managed course of steroids effectively puts the condition into remission while the body heals. 

Second-line immunosuppressant medications 

When corticosteroids are not sufficient or if a patient experiences significant side effects, doctors may prescribe second-line medications known as immunosuppressants or steroid-sparing agents. These drugs work by specifically targeting the immune cells responsible for the inflammation, allowing for a lower dose of steroids to be used. The most frequently used second-line medication in the UK is methotrexate, which is typically taken once a week. 

Other options include azathioprine, mycophenolate, and leflunomide, all of which require regular blood tests to monitor liver and kidney function. NICE clinical standards indicate that these medications are often introduced when the condition is chronic or when it affects vital systems like the heart or nervous system. These treatments are managed by specialists to ensure the immune system is suppressed just enough to control the sarcoidosis without making the patient vulnerable to other infections. 

Advanced biological therapies 

Biological therapies are a more advanced type of medication reserved for severe cases of sarcoidosis that have not responded to standard treatments. These drugs, such as infliximab or adalimumab, are monoclonal antibodies that target a specific protein in the immune system called tumour necrosis factor (TNF). This protein is a key driver of the inflammatory process that creates and maintains granulomas in the body. 

Infliximab is usually administered via an intravenous infusion in a hospital setting, while adalimumab is often given as an injection. These therapies are typically used for “refractory” sarcoidosis, where the inflammation persists despite the use of steroids and immunosuppressants. Because these are potent medications, they are only prescribed under strict clinical criteria and are monitored closely by specialist teams to ensure long-term safety and effectiveness. 

Topical and localised treatments 

For individuals whose sarcoidosis is limited to the skin or eyes, localised treatments can often reduce inflammation without the need for systemic tablets. Corticosteroid eye drops are frequently used to treat ocular sarcoidosis, helping to clear inflammation and protect vision. Similarly, steroid creams or gels can be applied directly to sarcoidosis skin rashes to reduce redness and flatten raised patches. 

These topical treatments allow for high concentrations of medication to reach the affected area while minimising the risk of side effects in the rest of the body. If the inflammation is particularly stubborn, a specialist might recommend local injections of corticosteroids into a specific skin lesion or around the eye. This targeted approach is a standard part of UK dermatological and ophthalmic care for sarcoidosis patients. 

Comparison of medication types for sarcoidosis 

The following table provides an overview of the different categories of medication used to manage inflammation. 

Medication Type	Common Examples	Primary Use	Mode of Action
Corticosteroids	Prednisolone	First-line for most active cases.	General immune suppression.
Immunosuppressants	Methotrexate, Azathioprine	Steroid-sparing in chronic cases.	Targets specific immune cells.
Biologicals	Infliximab, Adalimumab	Severe or resistant (refractory).	Blocks TNF inflammatory protein.
Topical	Steroid drops or creams	Skin or eye involvement.	Localised reduction of swelling.
Anti-malarials	Hydroxychloroquine	Specific skin or high calcium cases.	Modulates the immune response.

Monitoring and adjusting the treatment plan 

Because sarcoidosis is an unpredictable condition, the treatment plan is reviewed and adjusted regularly based on how the patient’s body responds. Doctors use lung function tests, blood tests, and imaging like X-rays to see if the granulomas are shrinking and if the inflammation is subsiding. If the condition appears to be in remission, the dose of medication is slowly tapered down to see if the body can maintain stability on its own. 

Consistent monitoring is also essential for managing the potential side effects of these medications. For example, patients on long-term steroids may have their bone density monitored, while those on methotrexate will have frequent liver function checks. This balanced approach ensures that the inflammation is controlled effectively while the patient’s general health is protected throughout the duration of their treatment. 

Conclusion 

The medications used to reduce inflammation in sarcoidosis range from standard corticosteroids like prednisolone to advanced biological therapies for resistant cases. While many people with mild disease may only require clinical monitoring, those with active inflammation have access to effective treatments that dampen the immune response and prevent organ damage. Regular specialist oversight ensures that these medications are used safely and adjusted according to the body’s natural recovery. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. This is particularly important if you experience sudden difficulty breathing, severe chest pain, or a sudden change in your heart rate or vision. 

Authority Snapshot (E-E-A-T Block) 

This article was developed to provide the public with clear and factual information regarding the pharmaceutical management of sarcoidosis. The content is authored and reviewed by UK-trained medical professionals and adheres strictly to clinical guidelines provided by the NHS and NICE. Our priority is ensuring that health information is accurate, safe, and aligned with current UK medical standards.